Variations in Inflammatory Cells and IL-6 in Long-Distance Runners Susceptible to Exercise-Induced Bronchospasm and Previously Treated with Salbutamol ()
Author(s)
Florent Nsompi1,2,3,
Alain Marc Boussana1,3,
Paul Roger Mabounda Kounga1,3,
Albérick Tito2,
Simplice Innocent Moussouami1,
Eddie Janvier Bouhika1,
Folly Messan2
Affiliation(s)
1Laboratory of Molecular and Cellular Biology, Physical Activity and Health, Higher Institute of Physical Education and Sport (ISEPS), Marien Ngouabi University, Brazzaville, Republic of Congo.
2Respiratory, Hormonal and Gerontological Sports Explorations Unit, National Institute of Youth, Physical Education and Sport (INJEPS), University of Abomey-Calavi (UAC), Porto-Novo, Benin.
3Laboratory Education, Health, Expertise and Motor Performance (LESEPM), Brazzaville, Republic of Congo.
ABSTRACT
Background: Exercise-Induced Bronchospasm (EIB) is an inflammatory condition characterized by severe airway constriction following the mobilization of inflammatory cells and interleukin-6 (IL-6). When severe, EIB can require the use of pressurized salbutamol to treat athletes. This study investigated the nature of the systemic changes in inflammatory cells and post-exercise IL-6 concentrations after salbutamol treatment in EIB-susceptible distance runners. Materials and Methods: This was an experimental study that enrolled 12 long-distance runners. In Session A, the participants completed a treadmill exercise test, and those who had a maximum expiratory volume per second (FEV1) that was decreased by at least 10% compared to their base value were placed in the EIB-susceptible group (EIB+) (n = 6). Those whose FEV1 did not meet this criterion were placed in the nonresponsive (EIB?) group (n = 6). Before the Session B exercise, athletes in the BIE+ group inhaled two puffs of salbutamol (EIB+ Salb), while their EIB? counterparts received no treatment. Spirometry was performed before and after the exercise using a Spirobank G portable spirometer. Blood samples were taken before, immediately after and 2 hours after the stress test. Results: The mean post-exercise FEV1 values were not significantly different (p > 0.05) between the EIB+ Salb group and the EIB? group. The systemic changes in inflammatory cells and IL-6 concentrations in the EIB+ runners after salbutamol treatment were similar to those observed in their EIB? counterparts. Conclusion: Salbutamol pretreatment improved the systemic immune status of EIB-susceptible athletes.
Share and Cite:
Nsompi, F. , Boussana, A. , Kounga, P. , Tito, A. , Moussouami, S. , Bouhika, E. and Messan, F. (2023) Variations in Inflammatory Cells and IL-6 in Long-Distance Runners Susceptible to Exercise-Induced Bronchospasm and Previously Treated with Salbutamol.
Journal of Biosciences and Medicines,
11, 32-46. doi:
10.4236/jbm.2023.111005.
Cited by
No relevant information.